World News

Malaria Vaccine Shows Success in Small Test Group

U.S. researchers say they have successfully tested a malaria vaccine on a small group of volunteers. The researchers say the vaccine is safe, that it caused a response in the volunteers' immune systems and that it protects against malaria infection in healthy adults.

People get malaria from a mosquito that is infected with malaria parasites. This vaccine contains weakened malaria parasites in an immature stage of their life cycle. Future studies will assess the different doses of the vaccine against other strains of parasites and will test for the length of time that the vaccine is effective.

The World Health Organization reports that malaria kills up to 800,000 people a year and that most deaths occur among children living in Africa. The WHO says in sub-Saharan Africa a child dies every minute from malaria.

Feature Story

FILE - satellite image provided by GeoEye shows the area around the Yongbyon nuclear facility in Yongbyon, North Korea

Exclusive: North Korean Ambassador Says His Country Will Keep Nuclear Program

Jang Il Hun accused the US of masterminding international criticism of his country’s human rights records to launch a smear campaign against the country’s political system More

Special Reports